HomePGEN • NASDAQ
Precigen Inc
$1.45
After Hours:
$1.44
(0.69%)-0.0100
Closed: Mar 28, 8:00:00 PM GMT-4 · USD · NASDAQ · Disclaimer
StockUS listed security
Previous close
$1.45
Day range
$1.42 - $1.47
Year range
$0.84 - $1.88
Market cap
360.93M USD
Avg Volume
1.16M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD)Dec 2023Y/Y change
Revenue
1.23M-30.35%
Operating expense
10.26M-10.82%
Net income
-33.06M-49.06%
Net profit margin
-2.69K-114.00%
Earnings per share
-0.0919.91%
EBITDA
-21.78M-31.95%
Effective tax rate
0.99%
Total assets
Total liabilities
(USD)Dec 2023Y/Y change
Cash and short-term investments
62.86M12.34%
Total assets
151.04M-30.07%
Total liabilities
32.54M-63.73%
Total equity
118.50M
Shares outstanding
248.92M
Price to book
3.02
Return on assets
-34.22%
Return on capital
-41.67%
Net change in cash
(USD)Dec 2023Y/Y change
Net income
-33.06M-49.06%
Cash from operations
-15.77M-2.40%
Cash from investing
13.29M16.39%
Cash from financing
0.00100.00%
Net change in cash
-2.49M94.25%
Free cash flow
-8.35M-123.68%
About
Precigen, Inc. is an American biotechnology company. Its president and CEO is Helen Sabzevari. Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells. Wikipedia
Founded
May 21, 1998
Employees
202
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu